Form 4: Sotera Health Director Sean Cunningham Receives Significant RSU Grant

Sotera Health Co. Director Sean Laurence Cunningham was granted 19,132 restricted stock units (RSUs) on May 22, 2025, increasing his total beneficial ownership to 80,781 shares.

Summary

• Sean Laurence Cunningham, a Director of Sotera Health Co. (SHC), acquired 19,132 shares of Common Stock on May 22, 2025.
• These securities are Restricted Stock Units (RSUs) granted under the Sotera Health Company 2020 Omnibus Incentive Plan, with a transaction price of $0 per share, indicating a grant rather than a purchase.
• Each RSU represents the right to receive one share of Common Stock, subject to specific vesting conditions.
• The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date (May 22, 2025), or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting.
• Vesting is contingent upon Mr. Cunningham's continued service as a non-employee director through the vesting date.
• Following this transaction, Mr. Cunningham's total beneficial ownership in Sotera Health Co. is 80,781 shares, which comprises the newly granted 19,132 RSUs and 61,649 previously held shares of Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While a Form 4 is primarily a disclosure of insider transactions, the grant of equity to a director is generally viewed favorably as it aligns management's interests with shareholders. There are no negative implications or risks identified in this specific filing.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their interests directly with those of the shareholders, as the value of their compensation is tied to the company's stock performance.
• Equity compensation for non-employee directors is a standard practice that helps attract and retain experienced board members.

Future Outlook

The Restricted Stock Units (RSUs) granted to Director Cunningham are subject to future vesting, which will occur on the earlier of the first anniversary of the grant date or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on his continued service as a non-employee director.

Industry Context

This Form 4 filing details a routine equity compensation grant to a non-employee director, which is a common practice across publicly traded companies, including those in the healthcare and medical sterilization sectors. Such grants are designed to align the interests of board members with long-term shareholder value.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to non-employee directors, with vesting tied to continued service and time, is a common and widely accepted practice for director compensation across various industries.
• This compensation structure is consistent with practices observed in comparable companies within the healthcare services and medical device sterilization sectors, such as Steris plc or Cantel Medical Corp. (prior to its acquisition by Steris), which frequently utilize equity-based incentives to attract and retain qualified independent directors.

Corporate Governance

Related Party Transactions

• The grant of 19,132 Restricted Stock Units (RSUs) to Director Sean Laurence Cunningham constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors. This is a standard form of director compensation.

Stakeholder Impact

• Shareholders: Positive impact due to increased alignment of a director's financial interests with the company's long-term performance through equity ownership.
• Employees: No direct impact mentioned in this filing.

Next Steps

• Vesting of the 19,132 Restricted Stock Units (RSUs) on the earlier of May 22, 2026, or the date immediately prior to Sotera Health Co.'s next regular annual shareholders meeting, subject to continued service.

Key Dates

Recommendation

Keywords

Sotera Health, SHC, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership, Insider Transaction